Pregnant women needed for blood clot study
NCT ID NCT06575309
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at how a common blood thinner (LMWH) works in pregnant women. Pregnancy naturally makes blood clot more easily, which can be risky. Researchers will use a special test to measure clotting in 50 pregnant women across all trimesters and after birth, to find the best dose of the blood thinner.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PREGNANT WOMEN are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU Estaing
RECRUITINGClermont-Ferrand, 63003, France
-
CHU de Clermont-Ferrand
NOT_YET_RECRUITINGClermont-Ferrand, 63000, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A new care protocol aims to support pregnant women in disaster zones
- Could a hidden back tissue hold the key to pelvic pain in pregnancy?
- Pregnancy's hidden strain: measuring the Back's inner support tissue
- Home kit boosts emotional bond between parents and unborn baby
- Which folate supplement works best for Moms-to-Be?
- Epidural analgesia in labor: could it shape your Baby's future?